Frontiers of Targeted Therapy and Predictors of Treatment Response in Systemic Sclerosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F22%3AN0000035" target="_blank" >RIV/00023728:_____/22:N0000035 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.3390/biomedicines10123053" target="_blank" >https://doi.org/10.3390/biomedicines10123053</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Frontiers of Targeted Therapy and Predictors of Treatment Response in Systemic Sclerosis
Original language description
Systemic sclerosis (scleroderma, SSc) is one of the most challenging rheumatic diseases, characterized by vasculopathy, dysregulation of the immune response, and progressive tissue fibrosis affecting the skin, lungs, heart, digestive tract, and kidneys
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30226 - Rheumatology
Result continuities
Project
<a href="/en/project/NV18-01-00161" target="_blank" >NV18-01-00161: Atherosclerosis and cardiovascular risk in selected rheumatic diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů